For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.
Testing Combined Chemotherapy and Radiation Therapy With and Without the Use of Atezolizumab Immunotherapy in Muscle Invasive Bladder Cancer
To compare the effects, good and/or bad, of chemotherapy and radiation therapy with or without the use of the immunotherapy drug atezolizumab, used to treat bladder cancer.
DiagnosisPatient has bladder cancer that has not spread beyond the bladder.
Confirmed Bladder Cancer T2-T4aN0M0
No Prior Chemotherapy for Bladder Cancer
No Prior Radiation
Patients must Sign Approved Informed Consent and Authorization Permitting Release of Personal Health Information
- Group 1: Radiation Therapy, One of the Usual Chemotherapy Regimens
- Group 2: Radiation Therapy, One of the Usual Chemotherapy Regimens and the Study Drug, Atezolizumab
- Quality of Life Questionnaires
For more information, visit ClinicalTrials.gov